EKR Therapeutics, Inc.
EKR Therapeutics Receives Two Additional Patents for Ready-to-Use Cardene(R) I.V. Bags, Providing Substantial Intellectual Property Protection Through 2027
Published in Hospital Law Weekly, March 4th, 2010
Previously, EKR was granted patent protection covering pharmaceutical formulations of its RTU Cardene I.V. bags, a specialty product line currently marketed in four different preparations for treating acute hypertension in emergency and critical-care settings. All three patents - formulation, method of treatment, and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2010-03-04)
More Articles from Hospital Law Weekly
- Betsy McCaughey
Needed: a Senator Who Will Look Out for New York and New Yorkers - Burn Care Research
Study data from Texas Technical University provide new insights into burn care research - Health and Society
Studies from Huazhong University of Science & Technology have provided new data on health and society - Heart Failure
New data from J.S. Ross et al illuminate research in heart failure - Life Sciences
Study findings on life sciences are outlined in reports from Medical University of Vienna, Department of Internal Medicine I - Massachusetts General Hospital
Rates of childhood obesity, chronic health problems increase, but conditions may not persist - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
